Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance
Top Cited Papers
- 3 May 2003
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (9) , 1561-1567
- https://doi.org/10.1016/s0735-1097(03)00189-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Molecular Genetic Basis for Hypertrophic CardiomyopathyJournal of Molecular and Cellular Cardiology, 2001
- The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial DysfunctionNew England Journal of Medicine, 2000
- Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel diseaseHeart, 2000
- Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic CardiomyopathyNew England Journal of Medicine, 2000
- Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathyThe American Journal of Cardiology, 1987
- Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathyJournal of the American College of Cardiology, 1986
- The current status of myocardial disarray in hypertrophic cardiomyopathy.Heart, 1984
- Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.Heart, 1980
- Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteriesThe American Journal of Cardiology, 1979
- Idiopathic Hypertrophic Subaortic StenosisCirculation, 1968